Abstract
Kasugamycin (KSM), an aminoglycoside antibiotic, is composed of three chemical moieties: D-chiro-inositol, kasugamine and glycine imine. Despite being discovered more than 50 years ago, the biosynthetic pathway of KSM remains an unresolved puzzle. Here we report a structural and functional analysis for an epimerase, KasQ, that primes KSM biosynthesis rather than the previously proposed KasF/H, which instead acts as an acetyltransferase, inactivating KSM. Our biochemical and biophysical analysis determined that KasQ converts UDP-GlcNAc to UDP-ManNAc as the initial step in the biosynthetic pathway. The isotope-feeding study further confirmed that 13C, 15N-glucosamine/UDP-GlcNH2 rather than glucose/UDP-Glc serves as the direct precursor for the formation of KSM. Both KasF and KasH were proposed, respectively, converting UDP-GlcNH2 and KSM to UDP-GlcNAc and 2-N’-acetyl KSM. Experimentally, KasF is unable to do so; both KasF and KasH are instead KSM-modifying enzymes, while the latter is more specific and reactive than the former in terms of the extent of resistance. The information gained here lays the foundation for mapping out the complete KSM biosynthetic pathway.
Funder
Ministry of Science and Technology (MOST), Taiwan
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference45 articles.
1. The structure of kasugamycin hydrobromide by x-ray crystallographic analysis;Ikekawa;J. Antibiot.,1966
2. Kasugamycin, a new antibiotic;Umezawa;Antimicrob. Agents Chemother.,1965
3. Structural analysis of kasugamycin inhibition of translation
4. Studies on the preventive effect of kasugamycin on rice blast;Ishiyama;J. Antibiot.,1965
5. Kasugamycin potentiates rifampicin and limits emergence of resistance in Mycobacterium tuberculosis by specifically decreasing mycobacterial mistranslation